First Time Loading...

Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 279.83 USD 0.19% Market Closed
Updated: May 6, 2024

Bio Rad Laboratories Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bio Rad Laboratories Inc
Cash from Financing Activities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Bio Rad Laboratories Inc
NYSE:BIO
Cash from Financing Activities
-$425.6m
CAGR 3-Years
7%
CAGR 5-Years
-54%
CAGR 10-Years
-3%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Financing Activities
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash from Financing Activities
-$144m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
17%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Financing Activities
-$859.6m
CAGR 3-Years
-5%
CAGR 5-Years
-17%
CAGR 10-Years
-13%
Agilent Technologies Inc
NYSE:A
Cash from Financing Activities
-$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
IQVIA Holdings Inc
NYSE:IQV
Cash from Financing Activities
-$382m
CAGR 3-Years
-21%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Bio Rad Laboratories Inc's Cash from Financing Activities?
Cash from Financing Activities
-425.6m USD

Based on the financial report for Dec 31, 2023, Bio Rad Laboratories Inc's Cash from Financing Activities amounts to -425.6m USD.

What is Bio Rad Laboratories Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-3%

The average annual Cash from Financing Activities growth rates for Bio Rad Laboratories Inc have been 7% over the past three years , -54% over the past five years , and -3% over the past ten years .